GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis-Reference-Cited by-同舟云学术

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis

Published:2023-11 Issue:21 Volume:68 Page:2607-2619
ISSN:2095-9273
Container-title:Science Bulletin
language:en
Short-container-title:Science Bulletin

Author:

Xiong Jie,Dai Yu-Ting,Wang Wen-Fang,Zhang Hao,Wang Chao-Fu,Yin Tong,Cheng Shu,Zhong Hui-Juan,Yu Shan-He,Jiang Lu,Wang Sheng-Yue,Fang Hai,Zhang Rui-Hong,Zhu Yue,Yi Hong-Mei,Jiang Xu-Feng,Chen Jia-Yi,Wang Li,Xu Peng-Peng,Chen Sai-Juan,Zhao Wei-Li

Funder

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

Changjiang Scholar Program, Ministry of Education

School of Medicine, Shanghai Jiao Tong University

National Natural Science Foundation of China

Shanghai Rising-Star Program

Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital

Samuel Waxman Cancer Research Foundation

Center for High Performance Computing, Shanghai Jiao Tong University

Shanghai Municipal Hospital Development Center

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference46 articles.

1. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology;Chen;Cell,2019

2. G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities;Martinez-Climent;Haematologica,2018

3. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines;Colin;Proc Natl Acad Sci USA,2013

4. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells;Schumann;Immunity,2010

5. Illuminating the onco-GPCRome: novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy;Wu;J Biol Chem,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights on Epstein-Barr virus-induced lymphomagenesis;Science Bulletin;2024-08

2. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma;Signal Transduction and Targeted Therapy;2024-03-06